Despite advances in coronary revascularization and widespread use of primary
percutaneous interventions, cardiogenic shock complicating an acute ST-elevation …

Background Acute myocardial infarction complicated by cardiogenic shock (AMI‐CS) is
associated with significant morbidity and mortality. Mechanical circulatory support (MCS) …

The role and timing of percutaneous mechanical circulatory support (MCS) devices in the
treatment of acute myocardial infarction complicated by cardiogenic shock (AMICS) are not …

Background: Despite advances in treatment, mortality in acute myocardial infarction (AMI)
complicated by cardiogenic shock (CS) remains high. Short-term mechanical circulatory …

Aims Evidence on the impact on clinical outcome of active mechanical circulatory support
(MCS) devices in cardiogenic shock (CS) is scarce. This collaborative meta-analysis of …

Abstract Treatment strategies to combat cardiogenic shock (CS) have remained stagnant
over the past decade. Mortality rates among patients who suffer CS after acute myocardial …

Background: Limited progress has been made in the management of cardiogenic shock
(CS). Morbidity and mortality of refractory CS remain high. The effects of mechanical …

Objectives: To review temporary percutaneous mechanical circulatory support devices for
the treatment of cardiogenic shock, including current evidence, contraindications …

Cardiogenic shock (CS) remains the most common cause of death in patients with acute
myocardial infarction although mortality could be reduced from formerly∼ 80% to 40–50 …

In patients with cardiogenic shock after acute myocardial infarction (AMI), mortality remains
high despite advances in treatment. Short-term percutaneous circulatory support devices …